Homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in mouse liver epithelial cells in culture

被引:0
|
作者
Miyasaka, K [1 ]
Kawauchi, S [1 ]
机构
[1] HOSHI UNIV, DEPT HYG CHEM, SHINAGAWA KU, TOKYO 142, JAPAN
关键词
mouse homolog; p16/CDKN2; immortalization; microsatellite; tumor suppressor gene;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The culture of hepatocytes isolated from C3H mouse liver results in the spontaneous development of colonies of liver epithelial cells that possess some features of the hepatocytes. These liver epithelial cells frequently have a loss of chromosome 4, and become neoplasms which are hepatocellular carcinomas by transfection with the activated c-Ha-ras gene, The suppression of malignant phenotypes by mouse chromosome 4 has already been shown by fusion between normal and malignant mouse cells, We established a total of six liver epithelial cell lines from C3H mice in order to investigate the presence of a tumor suppressor gene(s) on chromosome 4 in mouse hepatocarcinogenesis, and performed an allelotype analysis in seven microsatellites on chromosome 4 by the comparative multiplex PCR method. The result of analysis revealed that three of the six liver epithelial cells had allelic imbalances in four microsatellite loci, especially, two liver epithelial cell lines showed homozygous deletion in the D4MIT177 locus. Then, we investigated the status of the mouse homolog of p16/CDKN2 gene (mouse p16) on chromosome 4 by the comparative multiplex PCR method, and detected the homozygous deletion in two liver epithelial cell lines. Our result thus supports the theory that alterations of tumor suppressor gene(s) located on chromosome 4 may play a role in mouse hepatocarcinogenesis. Mouse p16, which is an inhibitor of cyclin dependent kinase 4, may suppress the cancer development in mouse hepatocarcinogenesis, or suppress liver cell immortalization.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 50 条
  • [1] Allelotype analysis in mouse hepatocellular carcinomas; Frequent homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in culture
    Miyasaka, K
    Fukui, T
    Kitagawa, T
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1996, 19 (05) : 683 - 691
  • [2] FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS
    CAIRNS, P
    POLASCIK, TJ
    EBY, Y
    TOKINO, K
    CALIFANO, J
    MERLO, A
    MAO, L
    HERATH, J
    JENKINS, R
    WESTRA, W
    RUTTER, JL
    BUCKLER, A
    GABRIELSON, E
    TOCKMAN, M
    CHO, KR
    HEDRICK, L
    BOVA, GS
    ISAACS, W
    KOCH, W
    SCHWAB, D
    SIDRANSKY, D
    [J]. NATURE GENETICS, 1995, 11 (02) : 210 - 212
  • [3] Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas
    Ono, Y
    Ueki, K
    Joseph, JT
    Louis, DN
    [J]. ACTA NEUROPATHOLOGICA, 1996, 91 (03) : 221 - 225
  • [4] Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients
    Mochizuki, S
    Iwadate, Y
    Namba, H
    Yoshida, Y
    Yamaura, A
    Sakiyama, S
    Tagawa, M
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (05) : 983 - 989
  • [5] Inactivation of the p16/CDKN2 gene in carcinomas of the hypopharynx
    Liengswangwong, U
    Konishi, N
    Hiasa, Y
    Naito, H
    Yane, K
    [J]. CANCER LETTERS, 1999, 143 : S33 - S33
  • [6] A frequent polymorphism in exon 1 of the p16/CDKN2 gene
    Fueyo, J
    GomezManzano, C
    Yung, WKA
    Zhang, W
    Lee, PSY
    Majumder, S
    Pershouse, M
    Levin, VA
    Kyritsis, AP
    [J]. MOLECULAR AND CELLULAR PROBES, 1995, 9 (06) : 465 - 466
  • [7] ANALYSIS OF THE P16 GENE (CDKN2) AS A CANDIDATE FOR THE CHROMOSOME 9P MELANOMA SUSCEPTIBILITY LOCUS
    KAMB, A
    SHATTUCKEIDENS, D
    EELES, R
    LIU, Q
    GRUIS, NA
    DING, W
    HUSSEY, C
    TRAN, T
    MIKI, Y
    WEAVERFELDHAUS, J
    MCCLURE, M
    AITKEN, JF
    ANDERSON, DE
    BERGMAN, W
    FRANTS, R
    GOLDGAR, DE
    GREEN, A
    MACLENNAN, R
    MARTIN, NG
    MEYER, LJ
    YOUL, P
    ZONE, JJ
    SKOLNICK, MH
    CANNONALBRIGHT, LA
    [J]. NATURE GENETICS, 1994, 8 (01) : 22 - 26
  • [8] Infrequent homozygous deletions of the p16 tumor suppressor gene (CDKN2) in sporadic primary melanoma.
    Bogenrieder, T
    Kroiss, M
    Bosserhoff, AK
    Rueschoff, J
    Hohenleutner, U
    Landthaler, M
    Stolz, W
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 57 - 57
  • [9] CHROMOSOME 9P ALLELIC LOSS AND P16/CDKN2 IN BREAST-CANCER AND EVIDENCE OF P16 INACTIVATION IN IMMORTAL BREAST EPITHELIAL-CELLS
    BRENNER, AJ
    ALDAZ, CM
    [J]. CANCER RESEARCH, 1995, 55 (13) : 2892 - 2895
  • [10] p16(CDKN2) gene polymorphism:: association with histologic subtypes of epithelial ovarian cancer in China
    Yan, L.
    Na, W.
    Shan, K.
    Xiao-Wei, M.
    Wei, G.
    Shu-Cheng, C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (01) : 30 - 35